SCHEMBL6239436

SCHEMBL6239436

CCOC(=O)CC(=O)c1cc(F)c(F)c(OC)c1OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MIF P14174 1/20 0.37
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
NLRP3 Q96P20 1/20 0.34
MAPT P10636 4/20 0.33
KAT6A Q92794 2/20 0.33
LMNA P02545 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HTT P42858 2/20 0.33
TNF P01375 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30181119 0.88 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL966496 0.88 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL9266273 0.84 MEN1 (0.50) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL6236981 0.83 KDM4E (0.48) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL1185918 0.79 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL30958584 0.79 ALDH1A1 (0.44) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL3197468 0.78 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL3190037 0.77 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL2601626 0.77 MEN1 (0.50) ALDH1A1KMT2AMEN1KDM4EMIF
SCHEMBL116517 0.77 MEN1 (0.50) ALDH1A1KMT2AMEN1KDM4EMIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532114-A2 PROCESS FOR PREPARING QUINOLONE ANTIBIOTIC INTERMEDIATES THE PROCTER & GAMBLE COMPANY (US) 2005-05-25 EP disclosed
US-6803469-B2 CYCLIZING IN THE PRESENCE OF A SILYLATING AGENT THE PROCTER & GAMBLE COMPANY 2004-10-12 US disclosed
US-20040063952-A1 Process for preparing quinolone antibiotic intermediates WARNER CHILCOTT COMPANY, LLC 2004-04-01 US disclosed
WO-2004013103-A2 PROCESS FOR PREPARING QUINOLONE ANTIBIOTIC INTERMEDIATES THE PROCTER & GAMBLE COMPANY (US) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063952-A1 Process for preparing quinolone antibiotic intermediates QPCT, CCNT1, TOP1 ALDH1A1 751/4885KMT2A 1408/4885MEN1 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.